Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
This study is currently recruiting participants.
Verified December 2012 by Astellas Pharma Inc
Study NCT01284192   Information provided by Astellas Pharma Inc

First Received on January 25, 2011.   Last Updated on December 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Malignancies
B-Cell Lymphoma
Solid Tumor
Additional conditions recognized in this trial
Lymphoma
Lymphoma, B-Cell
Neoplasms
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
ASP3026
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services